-Reuters
Citigroup Maintains Buy on Surgery Partners, Lowers Price Target to $38
Citigroup analyst Jason Cassorla maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price target from $49 to $38.
Related Posts
Why I-Mab Shares Are Jumping Today
I-Mab (NASDAQ: IMAB) has provided updates on the recent development relating to the Holding Foreign Companies Accountable Act (HFCAA) and its implementation.
I-Mab is not on this list, and it has taken proactive measures in response.
Telsey Advisory Group Maintains Market Perform on Dollar Tree, Raises Price Target to $132
Telsey Advisory Group analyst Joseph Feldman maintains Dollar Tree (NASDAQ:DLTR) with a Market Perform and raises the price target from $102 to $132.
Why Invacare Stock Is Trading Lower After Q3 FY21 Outlook Update
Invacare Corporation’s (NYSE:IVC) stock plunged to a 52-week low after updating Q3 FY21 guidance. The Company said that headwinds related…